Back to Search
RACHEL DILLMAN, PHARMD
PHARMD
Pharmacist
NPI: 1376929323Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
36268(SC)
Research & Publications (20)
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.
PMID 16550338·Clin Exp Med·2006
6-review
Developing an effective lung cancer program in a community hospital setting.
PMID 19632940·Clin Lung Cancer·2009
8-other
Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance.
PMID 19208427·Cancer·2009
8-other
Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy.
PMID 19421847·J Clin Immunol·2009
3-trial
Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.
PMID 19362957·Clin Lung Cancer·2009
3-trial
Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.
PMID 19538053·Cancer Biother Radiopharm·2009
8-other
Monitoring response to treatment in melanoma patients: potential of a serum glycomic marker.
PMID 17960619·Int J Cancer·2008
8-other
Monoclonal antibodies in cancer therapy: 25 years of progress.
PMID 18398141·J Clin Oncol·2008
7-preclinical
Abstracting height and weight from medical records, and breast cancer pathologic factors.
PMID 18618281·Cancer Causes Control·2008
8-other
Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells.
PMID 18454690·Cancer Biother Radiopharm·2008
3-trial
Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.
PMID 17651037·Cancer Biother Radiopharm·2007
8-other
Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathways.
PMID 17979570·Cancer Biother Radiopharm·2007
7-preclinical
Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
PMID 17600465·Cancer Biother Radiopharm·2007
3-trial
Improving survival for patients with breast cancer compared with intramural and extramural benchmarks.
PMID 17386125·Clin Breast Cancer·2007
8-other
Patient-specific dendritic-cell vaccines for metastatic melanoma.
PMID 16971731·N Engl J Med·2006
8-other
Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09.
PMID 16706633·Cancer Biother Radiopharm·2006
3-trial
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.
PMID 16966690·J Clin Oncol·2006
3-trial
Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes?
PMID 16114985·Cancer Biother Radiopharm·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 915 ANDERSON ST
PIEDMONT, SC 29673 - Phone
- (864) 845-8323
Quick Facts
- NPI
- 1376929323
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile